Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramsay Health CareASX:RHC +1.78%80 Cash-to-Debt is 0.07 as of Jun. 2026, which is 13% below its 10-year median of 0.08. GuruFocus rates ASX:RHC with a GF Score™ of 80/100 and a GF Value™ of A$40.77 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 670 Healthcare Providers & Services companies, Ramsay Health Care ranks worse than 89.1% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Ramsay Health Care's cash to debt ratio for the quarter that ended in Jun. 2026 was 0.07.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Ramsay Health Carecouldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2026.
The historical rank and industry rank for Ramsay Health Care's Cash-to-Debt or its related term are showing as below:
ASX:RHC'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03 Med: 0.08 Max: 0.2
Current: 0.07
During the past 13 years, Ramsay Health Care's highest Cash to Debt Ratio was 0.20. The lowest was 0.03. And the median was 0.08.
ASX:RHC's Cash-to-Debt is ranked worse than 89.1% of 670
companies
in the Healthcare Providers & Services industry
Industry Median: 0.785
vs ASX:RHC: 0.07
Ramsay Health Care (ASX:RHC) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Ramsay Health Care Cash-to-Debt Related Terms
Ramsay Health Care Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Ramsay Health Care's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Medical Care Facilities subindustry, Ramsay Health Care's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramsay Health Care Cash-to-Debt vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Health Care's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Ramsay Health Care's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ramsay Health Care (ASX:RHC) has a Cash-to-Debt of 0.07 as of Jun. 2026. This is 13% below median its historical median of 0.08. Over the past decade, Ramsay Health Care's Cash-to-Debt has ranged from 0.03 to 0.20. According to the industry distribution chart, Ramsay Health Care ranks #597 out of 670 companies in the Healthcare Providers & Services industry, placing it in the top 89.1%.
Is Ramsay Health Care's Cash-to-Debt too high?
Ramsay Health Care's current Cash-to-Debt of 0.07 is 13% below median its 10-year median of 0.08. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 0.20. The Healthcare Providers & Services industry median Cash-to-Debt is 0.79. Ramsay Health Care's value of 0.07 is 91.1% below this industry median. Based on the distribution chart, Ramsay Health Care ranks #597 out of 670 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Ramsay Health Care has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ramsay Health Care's Cash-to-Debt compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramsay Health Care ranks #597 out of 670 companies for Cash-to-Debt. This places Ramsay Health Care in the lower half of its industry. The industry median Cash-to-Debt is 0.79. Ramsay Health Care's value of 0.07 is 91.1% below this benchmark. Historically, Ramsay Health Care's own Cash-to-Debt has ranged from 0.03 to 0.20 over the past decade. While the company's 10-year median is 0.08 vs. the industry median of 0.79, Ramsay Health Care has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Healthcare Providers & Services company?
The median Cash-to-Debt among Healthcare Providers & Services companies is 0.79, based on 670 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramsay Health Care's current Cash-to-Debt of 0.07 is 91.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Cash-to-Debt is 0.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramsay Health Care's current Cash-to-Debt is 0.07, which is 13% below median its own 10-year median of 0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramsay Health Care stock overvalued right now?
Based on GuruFocus' analysis, Ramsay Health Care (ASX:RHC) is currently considered Significantly Overvalued. The stock's GF Value™ is A$40.77, compared to a current price of A$53.22 — trading 30.5% above its estimated fair value. The current Cash-to-Debt is 0.07, which is 13% below median its 10-year median of 0.08 and 91.1% below the Healthcare Providers & Services industry median of 0.79. Ramsay Health Care's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Ramsay Health Care (ASX:RHC), the current Cash-to-Debt is 0.07 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramsay Health Care (ASX:RHC) Overvalued in 2026?
Based on GuruFocus' analysis, Ramsay Health Care stock appears to be overvalued.
The current stock price of A$53.22 is trading 30.5% above its estimated GF Value™ of A$40.77.
GuruFocus considers Ramsay Health Care to be Significantly Overvalued.
Key valuation signals for ASX:RHC:
Cash-to-Debt: 0.07 (13% below median its 10-year median of 0.08)
GF Value™: A$40.77 vs. price of A$53.22 (30.5% above fair value)
Industry Position: 91.1% below the Healthcare Providers & Services median (#597 of 670)
No single metric tells the full story. See the ASX:RHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramsay Health Care is one of the largest private healthcare providers in the world, with more than 500 sites across about eight countries. The key markets in which it operates are Australia, France, the UK, and Sweden. It is the largest private hospital group in each of these markets except for the UK, where it is the largest independent supplier to the NHS. Ramsay Santé, which operates the European regions other than the UK, is a 53%-owned subsidiary of Ramsay Health Care. The company typically earns about two-thirds of consolidated earnings in Australia. Ramsay Health Care undertakes both private and publicly funded healthcare.
80GF Score
Get the complete analysis for ASX:RHC
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:RHC has been successfully added to your 
